FdaApplication

ANDA 212930

Back to search

Identifiers

Properties

PropertyValue
applicant_nameACCORD HEALTHCARE INC
application_typeANDA
approval_date2021-05-18

Products (2)

ProductActive ingredientStrengthDosage form
RANOLAZINERANOLAZINE1GMTABLET, EXTENDED RELEASE;ORAL
RANOLAZINERANOLAZINE500MGTABLET, EXTENDED RELEASE;ORAL

2 products